Clinical Discussion: Emerging Front-Line Treatments in Metastatic Bladder Cancer: IO + Chemotherapy, IO + ADC Therapy, and the Role of Biomarkers

Medscape
America/New York GMT -4 summer

Description

Emerging Front-Line Treatments in Metastatic Bladder Cancer: IO + Chemotherapy, IO + ADC Therapy, and the Role of Biomarkers will feature a discussion by Memorial Sloan Kettering-based genitourinary oncology expert Dr Jonathan Rosenberg. He will cover emerging strategies and the use of biomarkers in this setting. There will be time allotted for questions at the end of the broadcast.

Clinical Discussion: Emerging Front-Line Treatments in Metastatic Bladder Cancer: IO + Chemotherapy, IO + ADC Therapy, and the Role of Biomarkers

Inglês

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES
 

Speakers

Jonathan Rosenberg

 
 
 
 

Download the Agenda

Search for our next event. See you soon!

Subscribe to get news on all upcoming events

who%20goals_edited.png

DocMeeetings

Social Media

  • Twitter DocMeetings
  • Instagram DocMeetings
  • Facebook ícone social
  • LinkedIn ícone social

contact us

Adress

Sao Paulo, SP - Brazil

© 2020 by Docmeetings - A DocMeetings.com Company
Site Managed by:
QUALITY Soluções Web
1996-2020 "24 years inspiring technology"